Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03009981
Title A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.

prostate adenocarcinoma


Abiraterone + Apalutamide + Degarelix + Prednisone

Apalutamide + Degarelix


Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.